期刊文献+

HPLC法测定血清中替诺昔康浓度 被引量:2

HPLC determination of tenoxicam in serum
下载PDF
导出
摘要 目的 :建立测定血清中替诺昔康 (TNX)浓度的HPLC法。方法 :色谱条件 :KR10 0 C8色谱柱 ,流动相为含 5mmol·L-1庚烷磺酸钠的磷酸盐缓冲液 (pH =2 8) 乙腈 ( 6 5∶35 ,V/V) ,流速 1mL·min-1,测定波长 35 5nm ,内标为吡罗昔康 ,以TNX与内标的峰高比定量。结果 :线性范围为 0 0 5~ 10mg·L-1,具有良好的线性关系 ,日内、日间RSD均 <10 % ,相对回收率 >90 %。结论 :该方法简便、快速 ,灵敏度和准确度较高 ,无干扰。 AIM:To establish the reversed phase HPLC method for the analysis of tenoxicam(TNX) in serum METHODS:The KR100 C 8 column was used to detect the concentration of TNX The mobile phase consisted of a mixture of phosphate buffer saline(pH=2 8,which was added 5 mmol·L -1 sodium 1 heptanesulfonate)/acetonitrile (V/V,65/35) The flow rate was 1 0 mL·min -1 The detector wavelength was 355 nm The internal standard was piroxicam RESULTS:A good linearity was obtained within the range of 0 05 10 mg·L -1 of TNX with r= 0 999 7 The RSD of intra day and inter day variation of TNX were less than 10% The relative recovery of the method was more than 80% CONCLUSION:The method is simple,accurate and efficient for determination of TNX in serum
出处 《中国临床药学杂志》 CAS 2003年第6期358-359,共2页 Chinese Journal of Clinical Pharmacy
关键词 HPLC法 测定 血清 替诺昔康 浓度 吡罗昔康 tenoxicam HPLC piroxicam
  • 相关文献

参考文献5

  • 1Seaglione F, Demartini G, Dugmni S, et al. Pharmaeokineties of tenoxicam at different dosage regimen[J]. Farmaeo, 1993,48(9) : 1321.
  • 2Guentert TW, Stebler T, Banken L, et al. Relative bioavailability of oral dosage forms of tenoxicam[J]. Arzneimittelforsch, 1994,44(9) : 1051.
  • 3Munera-Jaramillo MI,Botero-Garces S.Dectermination of tenoxicam in plasma by high-performance liquid chromatography[J].J Chromatogr,1993,616(2):349
  • 4Walily AF, Blaih SM, Barmy MH, et sl. Simultaneous determination tenoxicam and 2-aminopyridine using derivative spectrophotometry and hig-performance liquid chromatography [J]. J Pharm Biomed Anal,1997,15(12):1923.
  • 5Stebler T, Gunetert TW. Bioavailability of intramuscularly administered tenoxicam[J]. Biopharm Drug Dispos, 1993,14(6) :483.

同被引文献8

  • 1Scaglione F,Demartini G,Dugnani S,et al.Pharmacokinetics of tenoxicam at different dosage regimen[J].Farmaco,1993,48(9):1321-1326.
  • 2Munera-Jaramillo MI,Botero-Garces S.Determination of tenoxicam in plasma by high-performance liquid chuomatography[J].J Chromatogr,1993,616(2):349-355.
  • 3Walily AF,Blaih SM,Barary MH,etal.Simultaneous determination of tenoxicam and 2-aminopyridine using derivative spectrophotometry and high-performance liquid chromatography[J].J Pharm Biomed Anal,1997,15(12):1923-1930.
  • 4Wiesner JL,Jager AD,Sutherland FCW,Hundt HKL,Swart KJ,Hundt AF.Sensitive and rapid liquid chromatography-tandem mass spectrometry method for the determination of meloxicam in human plasma[J].J Chromatogr B,2003,785:115-121.
  • 5Mairanovskii SG.The theory of catalytic hydrogen waves in organic polarography[J].J Electroanal Chem,1963,6(8):77-118.
  • 6杭太俊,张正行.替诺昔康的核磁共振光谱分析[J].中国药科大学学报,1997,28(5):285-287. 被引量:1
  • 7陈光亮,魏伟,沈玉先,李常玉,吴成义,徐叔云,许建明,胡咏梅,徐新华,梅俏,张磊.替诺昔康片人体生物等效性研究[J].中国药理学通报,2003,19(9):1058-1061. 被引量:3
  • 8徐积恩,刘松林.昔康(Oxicam)类非甾体消炎镇痛药的现状和动向[J].药学进展,1992,16(1):20-23. 被引量:10

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部